Neuroligin-1 Protein
Overview
Pathway Diagram
graph TD
NLGN1["NLGN1"]
style NLGN1 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
NLGN1 -->|"binds"| heparan_sulfate["heparan sulfate"]
NLGN1 -->|"interacts"| PSD95([PSD95])
NLGN1 -->|"participates in"| synapse["synapse"]
NLGN1 -->|"interacts"| neurexin([neurexin])
NLGN1 -->|"regulates"| GluA1([GluA1])
NLGN1 -->|"regulates"| Trans_Synaptic_Adhesion_Molecu["Trans-Synaptic Adhesion Molecule Modulation"]
NLGN1 -.->|"inhibits"| Alzheimer["Alzheimer"]
NLGN1 -.->|"inhibits"| Dementia["Dementia"]
NLGN1 -.->|"inhibits"| Als["Als"]
h_fdaae8d9["h-fdaae8d9"] -->|"targets"| NLGN1
Hevin([Hevin]) -->|"regulates"| NLGN1
FN([FN]) -->|"regulates"| NLGN1
NRXN2A([NRXN2A]) -->|"interacts"| NLGN1
amyloid_beta_oligomers([amyloid-beta oligomers]) -->|"modulates"| NLGN1
NRXN3([NRXN3]) -->|"interacts"| NLGN1
EXOSOMES([EXOSOMES]) -.->|"inhibits"| NLGN1
ALZHEIMER([ALZHEIMER]) -.->|"inhibits"| NLGN1
NRXN2([NRXN2]) -->|"interacts"| NLGN1
DEMENTIA([DEMENTIA]) -.->|"inhibits"| NLGN1
...Neuroligin-1 Protein
Overview
Pathway Diagram
Mermaid diagram (expand to render)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Neuroligin-1 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NLGN1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Neuroligin-1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NLGN1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's Disease</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's disease</a>, <a href="/wiki/autism-spectrum-disorder" style="color:#ef9a9a">autism spectrum disorder</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-fdaae8d9" style="color:#ce93d8" title="Score: 0.34">Trans-Synaptic Adhesion Molecule Modulat...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">38 edges</a></td>
</tr>
</table>
Protein Name: Neuroligin-1
Gene Symbol: NLGN1
UniProt ID: Q13404 [@structure]
Molecular Weight: 160 kDa [@neuroliginb]
PDB IDs: 3BIW, 3VL8, 4C8V, 5JXS [@crystal]
Subcellular Localization: Postsynaptic membrane, [dendritic spines](/mechanisms/dendritic-spines)
Structure
Neuroligin-1 is a type I membrane protein: [@postsynaptic]
- Extracellular Domain: Acetylcholinesterase-like catalytic domain
- Transmembrane Region: Single-pass membrane anchor
- Cytoplasmic Tail: PDZ-binding motif for scaffolding proteins
- Multiple splice variants
- Alternative exon usage
- Cell type-specific expression
Biological Functions
Neuroligin-1 is a critical postsynaptic adhesion molecule:
Synaptogenesis
- Induces presynaptic differentiation
- Recruits postsynaptic proteins
- Forms excitatory synapses (via NRXN1)
Synaptic Transmission
- Modulates postsynaptic receptor clustering
- Regulates NMDA/AMPA receptor function
- Controls synaptic vesicle release
Synaptic Plasticity
- Involved in [LTP](/mechanisms/long-term-potentiation) and LTD
- Activity-dependent modifications
- Learning and memory processes
Alternative Splicing
- Alternative exons affect binding specificity
- Regulated during development
- Altered in disease states
Role in Neurodegenerative Diseases
Alzheimer's Disease [@neuroliginc]
Synaptic Dysfunction
Synaptic loss: Early hallmark of AD
NLGN1 expression: Reduced in AD brain
Amyloid interaction: [Aβ](/proteins/amyloid-beta) affects neuroligin function
Memory formation: Required for synaptic plasticityPotential Mechanisms
- Altered splicing
- Reduced surface expression
- Impaired PSD interactions
Autism Spectrum Disorders [@autismassociated]
Genetic Associations
- NLGN1 mutations identified
- Copy number variations
- Rare pathogenic variants
Functional Consequences
- Impaired synaptogenesis
- Synaptic transmission deficits
- Social behavior abnormalities
Schizophrenia
- Reduced NLGN1 expression
- Postmortem brain studies
- GWAS associations
Cellular Interactions [@neuroligind]
Presynaptic Partners
- Neurexin-1 (NRXN1): Primary binding partner
- Alternative neurexin isoforms
- Calcium-dependent binding
Postsynaptic Partners
- PSD-95: Scaffolding protein
- GRIP1: PDZ domain interactions
- Gephyrin: Inhibitory synapses
Therapeutic Implications
Drug Development
- Neuroligin enhancers
- Small molecule stabilizers
- Peptide mimetics
- Gene therapy approaches
Biomarker Potential
- CSF protein levels
- Peripheral expression
- Genetic testing
Research Highlights
Model Systems
- Knockout mice: Viable with subtle deficits
- Transgenic mice: Synaptic changes
- Human [neurons](/entities/neurons): iPSC-derived
- Organoid models
Key Findings
- Essential for synapse formation
- Specificity through alternative splicing
- Developmental regulation
- Disease-associated mutations
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
Disease Mechanisms
Synaptic Homeostasis
Neuroligin-1 maintains synaptic homeostasis through several mechanisms: [^11]
Receptor clustering: Recruits and clusters postsynaptic receptors
Scaffold recruitment: Brings PSD-95 and other scaffolding proteins
Signaling complexes: Forms signaling platforms at synapsesActivity-Dependent Regulation
- [Alternative splicing*: Activity-dependent splice variants](/genes/ar)
- [Surface expression*: Regulated trafficking to membrane](/genes/ran)
- Endocytosis: Controlled internalization and recycling
- [Degradation*: Regulated turnover](/diseases/late)
Genetic Studies
Population Genetics [^12]
- [Common variants in general population](/genes/ar)
- [Rare pathogenic mutations in neurodevelopmental disorders](/genes/ar)
- [Co](/liquid-biopsy-cbs)py number variations
- Expression quantitative trait loci (eQTLs)
Family Studies
- Autosomal dominant inheritance patterns
- De novo mutations
- Variable penetrance
- Phenotypic heterogeneity
Clinical Relevance
Biomarkers
- Peripheral blood mononuclear cell expression
- Postmortem brain tissue analysis
- Induced neuron models from patient cells
- CSF analysis (experimental)
Therapeutic Targets
Small Molecules
- Neuroligin-1 stabilizers
- Splicing modulators
- Receptor interaction enhancers
Gene Therapy
- AAV-mediated expression
- CRISPR-based corrections
- Antisense oligonucleotides
Research Models
Animal Models
- Knockout mice: Synaptic deficits
- Transgenic mice: Disease models
- Zebrafish: Developmental studies
Cellular Models
- Primary neuron cultures
- Induced pluripotent stem cells (iPSC)
- Organoid cultures
- Heterologous expression systems
Future Directions
Emerging Research Areas
Single-cell analysis: Cell type-specific expression
Circuit-level studies: In vivo functionality
Structural studies: New crystal structures
Clinical translation: Therapeutic developmentUnresolved Questions
- Complete mechanism of synaptogenic function
- Specificity determinants
- Therapeutic window
- Long-term effects of modulation
References (Continued)
[Neuroligin-1 in synaptic homeostasis](https://pubmed.ncbi.nlm.nih.gov/23381566/)
[Population genetics of neuroligin genes](https://pubmed.ncbi.nlm.nih.gov/26235911/)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Trans-Synaptic Adhesion Molecule Modulation](/hypothesis/h-fdaae8d9) — <span style="color:#ff8a65;font-weight:600">0.34</span> · Target: NLGN1
Pathway Diagram
The following diagram shows the key molecular relationships involving Neuroligin-1 Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)